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Policy & Management, Erasmus University Rotterdam, Rotterdam, The NetherlandsA B S T R A C TBackground: Productivity losses often contribute signiﬁcantly to the
total costs in economic evaluations adopting a societal perspective.
Currently, no consensus exists on the measurement and valuation
of productivity losses. Objective: We aimed to develop a stand-
ardized instrument for measuring and valuing productivity losses.
Methods: A group of researchers with extensive experience in
measuring and valuing productivity losses designed an instrument
suitable for self-completion, building on preknowledge and evidence
on validity. The instrument was designed to cover all domains of
productivity losses, thus allowing quantiﬁcation and valuation of all
productivity losses. A feasibility study was performed to check the
questionnaire’s consistency and intelligibility. Results: The iMTA
Productivity Cost Questionnaire (iPCQ) includes three modules
measuring productivity losses of paid work due to 1) absenteeism
and 2) presenteeism and productivity losses related to 3) unpaid
work. Questions for measuring absenteeism and presenteeism were
derived from existing validated questionnaires. Because validatedee front matter Copyright & 2015, International S
r Inc.
.1016/j.jval.2015.05.009
ns@bmg.eur.nl.
ndence to: Clazien Bouwmans, Institute for Medica
rdam, The Netherlands.measures of losses of unpaid work are scarce, the questions of
this module were newly developed. To enhance the instrument’s
feasibility, simple language was used. The feasibility study
included 195 respondents (response rate 80%) older than 18 years.
Seven percent (n ¼ 13) identiﬁed problems while ﬁlling in the
iPCQ, including problems with the questionnaire’s instructions
and routing (n ¼ 6) and wording (n ¼ 2). Five respondents
experienced difﬁculties in estimating the time that would be
needed for other people to make up for lost unpaid work. Con-
clusions: Most modules of the iPCQ are based on validated questions
derived from previously available instruments. The instrument is
understandable for most of the general public.
Keywords: absenteeism, presenteeism, productivity losses, unpaid work.
Copyright & 2015, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Economic evaluations are increasingly performed to aid decision
makers in allocating scarce health care resources. Such evalua-
tions provide information on the relative cost-effectiveness of a
(new) health care intervention compared with one or more
(existing) alternatives [1]. Especially when decisions regarding
the implementation or reimbursement of new interventions are
(partly) based on outcomes of economic evaluations, and these
outcomes thus inﬂuence access of patients to interventions, it is
essential that these economic evaluations be conducted consis-
tently and uniformly. A fundamental methodological choice,
typically strongly affecting cost-effectiveness outcomes, is the
perspective from which an economic evaluation is performed [2].Evaluations from a health care perspective normally aim to
include only those costs that fall on the health care budget (and
therefore may be seen as most relevant to health care decision
makers). From a theoretical viewpoint, it can be argued that
optimal (i.e., welfare maximizing) decision making is possible
only by taking a societal perspective [3]. Evaluations conducted
from the societal perspective aim to incorporate all relevant costs
and effects, regardless of where these occur [1]. An important
cost category relevant from this perspective (but not from the
health care perspective) is that of productivity costs. The value of
productivity changes owing to illness and treatment often
reﬂects a large part of the total costs related to health and health
care interventions [4] and may even exceed medical costs
[2]. Consequently, the decision regarding the inclusion ofociety for Pharmacoeconomics and Outcomes Research (ISPOR).
l Technology Assessment, Erasmus University Rotterdam, PO Box
Table 1 – Summary of main criteria applied for the
development of the iMTA Productivity Cost
Questionnaire.
Objectives
Standardization: Generalizability and comparability
Building on preknowledge and evidence on reliability and validity
of existing questionnaires
Including absenteeism, presenteeism, and losses of unpaid work
Allowing to quantify productivity losses in descriptive and
monetary terms
Suitable for valuations based on the human capital approach and
the friction cost approach
Feasible to use for adults in a broad general population
Applicable in economic evaluations of health care interventions,
independent of the disease area
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cations for ﬁnal outcomes. Some have argued that performing
economic evaluations from both the societal and the health care
perspective would be most informative [5–7]. Such a two-
perspective approach is already recommended in several
national health economic guidelines [8–11]. Despite the fact that
some of the national health economic guidelines recommend a
two-perspective approach and approximately half of the guide-
lines prescribe taking a societal perspective (http://www.ispor.
org/peguidelines/index.asp), in practice productivity costs are
ignored in the vast majority of economic evaluations [2,5,12,13].
It is unclear why productivity costs are ignored in economic
evaluations so often. It has been suggested, however, that the
exclusion of productivity costs in economic evaluations is related
to a lack of guidance and standardization of measurement and
valuation of health-related productivity losses [14,15]. Indeed, most
health economic guidelines provide little or no guidance on how to
estimate productivity costs. Moreover, golden standards regarding
the measurement and valuation of productivity losses do not exist.
Speciﬁc guidance as to the types of productivity costs that should
be included in economic evaluations is generally limited as well
[16]. In addition, validated questionnaires for measuring produc-
tivity losses are scarce and not systematically applied [16].
Costs associated with health-related productivity changes are
commonly referred to as productivity costs and can be deﬁned as
“Costs associated with production loss and replacement costs
due to illness, disability and death of productive persons, both
paid and unpaid” [17]. Currently, the importance of inclusion of
productivity costs related to paid work in economic evaluations
taking a societal perspective is generally acknowledged. This is
not (yet) the case for unpaid work [18]. Nonetheless, unpaid work
clearly is an important source of economic value contributing to
overall welfare. Given that health care interventions are often
aimed at elderly populations who do engage in unpaid work but
not in paid work, inclusion of these costs can be highly relevant
in many studies. Three types of unpaid activities can be distin-
guished: household work (e.g., cooking and cleaning), care work
(e.g., taking care of children, helping friends or family with
cleaning and personal care), and volunteer work (e.g., helping
out in a commodity center or a sports club). Despite unpaid
work’s recognized importance, it is omitted from the vast major-
ity of economic evaluations, even those that claim to take a
societal perspective [4,18,19]. In addition, complete and validated
measurement instruments for unpaid work are lacking. For
instance, the measurement of unpaid work in the Health and
Labor Questionnaire was limited to household tasks taken over
by others [20]. The Work Productivity and Activity Impairment
questionnaire asks about the ability to perform these tasks, with
no opportunity to value in monetary terms [21].
Productivity changes in paid work may occur because of
absence from work (absenteeism) or because of reduced produc-
tivity while at work (presenteeism). Information on absence from
work due to sick leave may be derived from existing data sources
(if available), such as registrations from occupational health
service companies. Caution is warranted in using such sources,
because on important aspects such as age, health status, and
occupational background the people included in such registries
may differ from the population included in an evaluation study.
Moreover, such registrations are typically available only for sal-
aried workers and not for self-employed workers. Therefore, it is
advisable to directly measure productivity losses related to paid
work, ideally by monitoring actual production. In many circum-
stances, however, this is not feasible. Because of these restrictions,
often patients’ self-completed questionnaires are applied in col-
lecting productivity data for use in economic evaluations.
Today, various such instruments that have been developed
are available. Several of these instruments have been speciﬁcallydeveloped to measure health-related productivity losses. Most,
however, are not speciﬁcally intended or suited for use in eco-
nomic evaluations [22–24]. For instance, the measurements do not
always allow directly translating productivity losses into monetary
terms or the scope may be limited to losses related to paid work
only. Additional differences between the instruments concern the
formulation of separate questions, the inclusion of different types
of productivity losses, the length of the questionnaire, the recall
period, and the (implicitly assumed) valuation method. Regarding
the latter, it is important to note the (ongoing) debates regarding
preferred valuation methods for productivity losses [14,19]. Espe-
cially, the debate regarding the appropriateness of the human
capital approach and the friction cost approach received quite
some attention [25–32]. Applying these methods requires speciﬁc
information that measurement instruments need to facilitate.
Finally, not all instruments are speciﬁcally developed for self-
completion in a broad population. Consequently, all these factors
may affect the validity, completeness, generalizability, usefulness,
and comparability of outcomes of these instruments.
This article reports on the development of a standardized
instrument suitable for self-completion for measuring and valu-
ing all relevant productivity losses: the iMTA Productivity Cost
Questionnaire (iPCQ). For this purpose, we optimized the features
of existing instruments. Our underlying aim was to enhance the
generalizability and comparability of outcomes of economic
evaluations.Methods
Development
A group of well-experienced researchers in the ﬁeld of measuring
and valuing productivity losses for use in economic evaluations of
health care interventions was empanelled for the development of
a standardized instrument for measuring and valuing productiv-
ity losses. This group of researchers (all working at the Erasmus
University Rotterdam) consisted of four health economists (L.H.R.,
M. Koopmanschap, M. Krol, andW.B.) and two health scientists (C.
B. and H.S.). During three interactive brainstorming sessions of 2
hours, the approach for the development of the questionnaire
was discussed and the main quality criteria the instrument
should meet were drawn up. These criteria were based on up-
to-date scientiﬁc knowledge and practical experience of the
researchers involved. The criteria are summarized in Table 1.
It was decided to base the standardized instrument on
preexisting questionnaires by optimizing the features of these
instruments developed within or in cooperation with Erasmus
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HLQ) [20] and the PROductivity and DISease Questionnaire (PRO-
DISQ) [33]. A number of items included in these questionnaires
had already proved their usefulness in practice and had been
validated. The primary criterion for the selection of appropriate
questions for measuring different types of productivity losses
was evidence regarding the validity of the measurements.
In general, consensus exists on the relevance of productivity
losses of paid work for evaluations adopting a societal perspec-
tive. Nevertheless, productivity losses at work due to health
problems (presenteeism) are frequently omitted. Another impor-
tant area that is generally ignored concerns productivity losses of
unpaid work. Still, given the aging of Western populations, a
growing proportion of patients is retired. These patients, how-
ever, may still play an active role in society by performing
nonpaid jobs or volunteer activities and by providing informal
care [34]. The instrument needed to be able to capture all these
aspects.
Another important prerequisite was that the questionnaire
allowed for the quantiﬁcation of productivity losses in descriptive
terms (e.g., the number of days of absenteeism and presenteeism,
the amount of losses of/due to unpaid work) and in monetary
terms. Given the ongoing debate on whether productivity losses
are best valued with the friction cost approach or the human
capital approach [25–32,35] and the lack of practical consensus
[2,5,12,13], it was considered important that the questionnaire
was suitable for both approaches. To do so, questions about the
frequency and length of spells of absenteeism needed to be
included.
The instrument should be suitable for patient self-completion
to ensure efﬁcient data collection. It was discussed whether the
phrasing of the questions in the existing productivity cost instru-
ments used as the foundation for the iPCQ were sufﬁciently easily
understandable for most of the general public. Difﬁculty of
language could affect the validity and feasibility of the instru-
ment. Therefore, after completion of the design of the iPCQ
instrument, it was sent to a specialized agency (http://www.
bureautaal.nl) that rephrased the questions to language level
B1. This language level is based on the Common European
Framework of Reference for Languages, which plays a central
role in language and education policy worldwide. The Common
European Framework of Reference for Languages describes lan-
guage ability on a scale of levels from A1 for beginners up to C2
for those who have mastered a language. Most levels are
empirically validated (www.coe.int/lang-CEFR). Language level
B1 implies that the text can be comprehended by 95% of the
general population, including lower educated persons [36]. To
enhance the feasibility of the questionnaire, we kept the length of
the questionnaires as short as possible.
The questionnaire has been translated into English, and in the
future should be made available in multiple languages, allowing
its use in national and international studies.Results
General Structure of the Questionnaire
The iPCQ consists of 18 questions, of which 9 are general
questions to collect demographic information, such as age, sex,
and respondents’ work status (e.g., number of hours per week of
paid work and number of working days a week). Productivity
losses are measured in three separate modules, allowing the
option of leaving out speciﬁc types of productivity losses when
these are not relevant for a speciﬁc population. The question-
naire adopts a recall period of 4 weeks. This period is based on
research indicating that longer recall periods negatively affect theaccuracy of self-reported absenteeism [41]. Evidence regarding
the appropriate recall period for presenteeism, however, is
indecisive [19]. In addition, the questionnaire provides an easily
understandable general instruction for the respondent and rout-
ing instructions, allowing the respondent to easily skip questions
that are not applicable to individual responders.
Absenteeism
The iPCQ includes three questions for measuring productivity
losses due to absence from work. The questions originate from
the PRODISQ and the SF-HLQ and identify the occurrence of
absenteeism from paid work and the length of absenteeism. In
addition, the module includes a speciﬁc question to assess the
starting date of long-term absence from work. Long-term absence
in this context is deﬁned as absence starting before the recall
period. The validity of these questions was shown in a number of
studies [20,38,41].
Presenteeism
Three questions are included to identify health-related dimin-
ished productivity at work. The questions are a combination of
questions of the PRODISQ and the SF-HLQ. Respondents are
asked whether they suffered from health problems at work and
if so, for how many days (question originating from the SF-HLQ).
Next, respondents are asked to rate their work performance on
these days in comparison to their functioning on normal working
days using a 10-point rating scale. The latter question is derived
from the PRODISQ and based on the earlier developed Quantity
and Quality (QQ) method [37]. Brouwer et al. [39] examined the
construct and convergent validity of the alternative methods
applied in the SF-HLQ and the PRODISQ. They concluded that
estimates of productivity losses using the Quantity scale from the
PRODISQ resulted in a better cost estimation than from the so-
called Osterhaus method applied in the SF-HLQ. The Quantity
scale estimate was “considered to better indicate the real quan-
tity of lost productivity.” Reliability of presenteeism questions
was previously examined using a test-retest design [38]. A
satisfactory agreement was found on the reported efﬁciency
rates (intraclass correlation coefﬁcient of 0.729). In addition,
moderate agreement was found on the reported number of days
at work while impeded (intraclass correlation coefﬁcient 0.556).
Productivity Losses of Unpaid Work
The questions in the unpaid work module were developed during
two brainstorming sessions of the working group members.
Measurement and valuation of losses of unpaid work in the SF-
HLQ are limited to losses that are actually taken over by other
persons, hence ignoring lost production. The members of the
working group were of the opinion that all losses should be
measured, whether production was taken over or not, to avoid
underestimation.
To increase the measurements’ validity, unpaid tasks were
deﬁned. Respondents are asked whether they could perform less
unpaid work, such as household work and volunteer work, as a
result of health problems. Next, they are asked to state how
many hours it would take someone else to replace this unper-
formed unpaid work. The latter approach was chosen for several
reasons: 1) it ensures that all lost unpaid work is measured and
not only the work that is actually replaced by others; 2) it ensures
a reasonable estimate of required time of someone else (not
hampered by health problems); and 3) it applies a “third-person
criterion” distinguishing unpaid work from leisure time. To
clarify, the third-person criterion denotes that all beneﬁts from
activities outside paid work that are replaceable by a third person
are considered unpaid labor [40].
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To be able to produce productivity cost estimates with the human
capital approach and the friction cost approach, the absenteeism
questions were constructed in such a way that they allow for
determining the length of individual absenteeism periods. This is
necessary because with the friction cost approach productivity
losses related to absenteeism are assumed to be restored after a
“friction period,” that is, the period required to replace an ill
worker.Manual
A manual was developed to provide practical support for apply-
ing the instrument and for measuring and valuing productivity
losses. The manual includes examples and instructions for
estimating costs of productivity losses of (long-term) absence
from work using the friction cost approach. In addition, the
manual provides a codebook for the registration of data.
In some cases, the basic questions of the iPCQ relating to
absence from work may not be feasible or appropriate, for
instance, when the health problems are characterized by episodic
exacerbations (e.g., migraine), which can cause strong ﬂuctua-
tions in patients’ productivity and frequent, short episodes of
absenteeism [20]. Such ﬂuctuating productivity patterns may ask
for a more intense monitoring of productivity changes. Therefore,
the iPCQ provides an alternative version for measuring these
short episodes of absenteeism, which was derived from the
Health and Labor Questionnaire. This version consists of daily
log reporting on presence or absence from work. The validity of
the daily log reports was assessed previously [20]. These alter-
native questions are included in the manual.
The questionnaire and the manual are available in Dutch and
in English. The questionnaire is suitable for interview adminis-
tration, traditional self-completion in writing, and Web-based
applications.Table 2 – Characteristics of respondents in the
feasibility study (N ¼ 195).
Characteristic Value
Age (y), mean  SD 51.4  17.7
Sex: male, n (%) 70 (36)
Education, n (%)
Low 20 (10)
Secondary 71 (37)
High 97 (40)
Living with partner, n (%) 130 (67)
Paid work (%) 121 (62)Validation
The validity of several elements of the iPCQ originating from the
preexisting instruments was previously investigated. As
explained, the questions regarding unpaid work were newly
developed. Although all modules need further validation, con-
sequently this implies that especially for the unpaid work
module additional research is necessary to assess its reliability
and validity.
All questions were rephrased by a specialized agency to make
the questionnaire suitable for a broad general population. A
feasibility study was conducted as the ﬁrst step in the validation
process of the iPCQ. This study was designed to test the
consistency and intelligibility of the questionnaire. For this
purpose, a convenience sample from the general population
was asked to complete the iPCQ and to indicate whether it
considered certain questions unclear. In addition, respondents
were able to comment on the questionnaire’s instructions and its
routing. Two students each randomly invited 100 adults from
public places (e.g., shops, marketplaces, and passengers in public
local transport) and relatives to participate in the study. An
additional number of respondents was recruited by colleagues
from our institute. The questionnaire was completed in writing.
Respondents were asked to mark questions that were difﬁcult to
understand. The reason why the question was considered difﬁ-
cult to answer had to be reported in a separate document. Finally,
respondents were asked to comment on the questionnaire and its
structure. Questionnaires were returned by mail. Participation in
the study was encouraged by allotting three vouchers of €50
among respondents. Responsiveness and ease of administrationwere also evaluated by measuring the questionnaire’s comple-
tion time of 30 participants by each of the students.
The feasibility study included a total of 195 respondents 18
years and older (response rate 80%).
As can be seen in Table 2, 36% of the respondents were men;
25% reported a middle-level education, and 50% reported a higher
level of education. A total of 62% were in paid profession. Ten
percent of the respondents in paid profession reported having
experienced absenteeism in the preceding 4 weeks, and 30% had
experienced health problems at work affecting their level of
productivity. The number of respondents experiencing problems
in completing the iPCQ was small (n ¼ 13). Two respondents
reported that the routing from short-term absence from work to
long-term absence was unclear. This routing between these
questions was subsequently revised. Two respondents men-
tioned that explanatory statements preceding speciﬁc questions
were overlooked because of routing instructions. In response to
these comments, the placement of these instructions was
revised. In addition, two respondents pointed out that the routing
to the end of the questionnaire was unclear at some points.
These routing instructions were revised. Two respondents indi-
cated that the wording of the question on absence from work was
confusing. Consequently, the wording was revised.
Five respondents experienced difﬁculties in estimating the
amount of time that would be needed for other people to make
up for lost unpaid work. Although we acknowledge the relative
difﬁculty of this question, an easier yet (theoretically) correct
alternative for this question is currently unavailable. For 60
respondents, the time to complete the iPCQ was measured. On
average, the time to complete the iPCQ was 4.8 ( 2.6) minutes.Discussion
This article reports on the development of the iPCQ, a stand-
ardized instrument for measuring and valuing productivity losses
for use in economic evaluations of health care. Where possible,
the development of the instrument was based on previously
available instruments. The iPCQ is a short and concise instru-
ment suitable for quantifying presenteeism at and absenteeism
from paid work as well as productivity losses related to unpaid
labor. The iPCQ has a modular structure that allows selecting
relevant components of productivity losses for individual studies.
The instrument is suitable for self-reporting, online use, and
face-to-face interviewing. To enhance feasibility and responsive-
ness, the questions in the iPCQ are phrased in such a way that
the questions are easily understandable for most of the general
public, including low-educated people. In addition, to increase its
feasibility, also in the context of patient self-reported measure-
ments, the number of questions of the instrument is limited. On
average, it took our convenience sample less than 5 minutes to
complete the questionnaire.
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noted. First, the iPCQ adopts a 4-week recall period, on the basis
of previous research indicating less accurate reporting for longer
recall periods [41]. This period is normally shorter than the
interval of follow-up measurements in evaluation studies, in
which measurements every 4 weeks are rare for practical rea-
sons. This implies that interpolation and extrapolation of the
measured productivity losses are necessary to cover the full
evaluation period. Evidence regarding the appropriate length of
recall periods for presenteeism is indecisive [19]. This topic
therefore deserves more attention in the literature. For clarity
and convenience of respondents, the recall period for presentee-
ism was set equal to that of absenteeism (i.e., 4 weeks). For
reasons of reliability and comparability, we strongly advise to
align with this recall period when using the iPCQ. It is important
to realize that the validity of the measurements is inﬂuenced by
three important aspects: recall bias, measurement quantity, and
measurement gaps. Recall bias is likely to increase with longer
recall periods. Shorter recall periods will result in an increase in
either measurement moments or measurement gaps, needing
interpolation between measurement moments. Consequently,
decisions regarding recall periods should be taken with caution.
Acceptable duration of measurement gaps depends on the
ﬂuctuation of productivity losses within the population of
interest.
Second, the iPCQ does not include questions regarding com-
pensation of lost productivity or regarding the effects of dimin-
ished productivity on coworkers (so-called multiplier effects).
Empirical research has shown that coworkers often compensate
productivity losses during regular hours [42–44] and that absen-
teeism and presenteeism can negatively affect the productivity of
coworkers in cases of team dependency [45–47]. To what extent
such mechanisms affect ﬁnal production and actual costs, how-
ever, remains largely unclear. Therefore, adjusting productivity
costs for compensation mechanisms or multiplier effects is
premature. If future research provides insight into how to
properly cope with compensation mechanisms and multiplier
effects, in terms of not only their measurement but also their
effect on actual costs, the iPCQ may need to be updated.
Third, regarding the measurement of unpaid work, the work-
ing group did not support current ways of including this in
available instruments. Moreover, the limited amount of available
scientiﬁc studies discussing unpaid labor offered little guidance
regarding appropriate measurement approaches. Consequently,
the questions in the unpaid work module were based on expe-
rience of the working group members. This implies that espe-
cially this module needs additional validation. We also
emphasize that unpaid work deserves more attention in the
scientiﬁc literature in general because it is often ignored while
it may be inﬂuential especially in groups such as elderly, who
often form a large part of treated patients.
Fourth, the iPCQ was developed using a modular structure
that facilitates excluding irrelevant modules. We do advise,
however, to exclude modules only after careful consideration
and clear justiﬁcation for doing so if one aims to conduct an
economic evaluation from the societal perspective.
Finally, it is important to realize that the iPCQ is an instru-
ment to quantify productivity losses (especially for use in
economic evaluations). It does not measure workability or role
functioning.
Although these aspects are important, they are commonly
included in quality-of-life measures. They are therefore not seen
as part of productivity per se, but as health effects and valued as
part of quality of life.
Despite critical notes, the development of the iPCQ offers a
valuable comprehensive tool to enhance the comparability and
generalizability of outcomes in economic evaluations adopting asocietal perspective. The application of standardized instruments
is an important prerequisite for increasing the comparability of
outcomes of economic evaluations. To test and to maintain the
quality of instruments, however, it is essential to extensively
validate instruments, to regularly assess the content on the basis
of (new) scientiﬁc developments, and to adjust the instrument
when necessary. Also, in that context, the validation of the iPCQ
is an ongoing process. It is currently applied in several economic
evaluations of interventions in different disease areas. The
results of these studies are expected in the near future, allowing
further assessment of the properties of the iPCQ and, where
possible and required, improvement based on new scientiﬁc
insights.Conclusions
The iPCQ is a concise generic instrument developed to quantify
health-related productivity losses of paid and unpaid work for
use in economic evaluations. It is largely based on previously
available instruments and builds on the current scientiﬁc state of
play in productivity cost measurement and valuation. The instru-
ment is unique in its language use because it has been especially
developed to be understandable for the vast majority of the
general public including low-educated people. Although many
of the items of the iPCQ have been previously validated, further
validation of the instrument is foreseen and encouraged. iPCQ is
currently available in Dutch and English. Translations in other
languages, for example, German, French and Spanish, is expected
in the near future.
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